Form 4: Myriad Genetics Executive Mark Verratti Reports Stock Transactions
SEC Form 4 Filing
Mark Verratti, Chief Commercial Officer of Myriad Genetics, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On October 9, 2024, Mark Verratti, the Chief Commercial Officer of Myriad Genetics, had shares of common stock withheld by the company to cover tax obligations.
- A total of 3,359 shares were withheld at a price of $24.37 per share to satisfy tax obligations related to the vesting of restricted stock units.
- An additional 5,004 shares were withheld at the same price to cover tax obligations related to the vesting of performance-based restricted stock units.
- Following these transactions, Verratti directly owns 289,277 shares of Myriad Genetics common stock.
Sentiment
Score: 5
Explanation: This is a neutral document detailing routine stock transactions for tax purposes, with no inherent positive or negative sentiment.
Industry Context
This is a routine SEC filing related to stock transactions by a company executive, which is common practice for publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 10/09/2024 | Date of stock transactions (shares withheld for tax obligations). |
| 10/10/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.